Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis Unveils Heart Failure Social Network
Investopedia
Sun, 11/27/16 - 04:02 pm
Tags:
Novartis, heart failure, social media
Novartis’ recently departed oncology R&D chief is headed back to Dana-Farber and a new job in cancer research
Endpoints
Wed, 11/23/16 - 10:18 am
Tags:
Novartis, oncology, R&D
Chiesi buys asthma company, pitting it against Novartis
BioPharma Dive
Tue, 11/22/16 - 11:26 am
Tags:
Chiesi, asthma, Novartis, Atopix Therapeutics
Novartis buys sickle cell player Selexys in $665M deal
Fierce Biotech
Mon, 11/21/16 - 11:34 am
Tags:
Novartis, Selexys, M&A, sickle cell disease
Novartis’s Alcon Continues Its Falling Trend in 3Q16
Market Realist
Fri, 11/18/16 - 10:10 am
Tags:
Novartis, Alcon, eye health
Drug Makers Target Psoriatic Arthritis
Investopedia
Thu, 11/17/16 - 04:44 pm
Tags:
psoriatic arthritis, Novartis, Celgene, Otezla, Cosentyx
Novartis’s Revenue Trend in 3Q16
Market Realist
Thu, 11/17/16 - 09:32 am
Tags:
Novartis, earnings
Novartis May Buy Generics Maker Amneal for $8B
Investopedia
Wed, 11/16/16 - 09:48 am
Tags:
Novartis, Amneal, generics, eye health, M&A
Novartis mulls sale for underperforming Alcon eye division
Mass Device
Mon, 11/14/16 - 10:50 pm
Tags:
Novartis, Alcon, devices, M&A
The Novartis house that Vasella built gets extreme makeover
Yahoo/Reuters
Mon, 11/14/16 - 10:43 am
Tags:
Novartis, Daniel Vasella, Alcon
Pfizer wins EU's approval for Ibrance as Novartis readies rival drug
Yahoo/Reuters
Thu, 11/10/16 - 11:21 am
Tags:
Pfizer, Europe, Ibrance, breast cancer, Novartis, ribociclib
Novartis Takes Aim at Pfizer
Motley Fool
Thu, 11/3/16 - 09:48 am
Tags:
Novartis, Pfizer, breast cancer, ribociclib, Ibrance
Novartis' Is Challenging Biogen on Biogen's Own Turf
Motley Fool
Wed, 10/26/16 - 09:19 pm
Tags:
Novartis, Biogen, Gilenya, Tecfidera, MS, multiple sclerosis
Merck and Novartis chiefs outline what’s on the M&A menu in 2017
Endpoints
Wed, 10/26/16 - 09:14 am
Tags:
Merck, Novartis, M&A
Novartis explains why it canned the cell therapy unit
BioPharma Dive
Wed, 10/26/16 - 09:09 am
Tags:
Novartis, cell therapy
Novartis promises a speedy CAR-T pitch, boasts about its slate of blockbusters-to-be
Endpoints
Tue, 10/25/16 - 10:10 am
Tags:
Novartis, CAR-T, CTL-019, acute lymphoblastic leukemia, diffuse large B-cell lymphoma
With no big M&A on tap, Novartis presses pause on $12B-plus Roche stake sale
Fierce Pharma
Mon, 10/24/16 - 11:51 pm
Tags:
Novartis, M&A, Roche
Novartis’s 3Q16 Estimates: Will Alcon Recover Its Growth?
Market Realist
Mon, 10/24/16 - 11:49 pm
Tags:
Novartis, Alcon, earnings
Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?
Fierce Pharma
Mon, 10/24/16 - 09:50 am
Tags:
Pfizer, drug launches, biosimilars, Inflectra, Amgen, Novartis
Novartis’s 3Q16 Estimates: Innovative Medicines Segment
Market Realist
Mon, 10/24/16 - 09:32 am
Tags:
Novartis, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.